Antibodies under a microscope

DHD80901

Research Grade Brentuximab

Description

SGN-35, cAC10-Val-Cit-MMAE, CAS: 914088-09-8, 2088770-90-3

Targets

CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30

Isotype/Mimetic

IgG1-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression